Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 30, 2024
Agilent Technologies Inc. announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and ...
read more
Monday, September 30, 2024
Axio BioPharma announced that it is now accepting recombinant protein manufacturing projects. Located within Forward BIOLABS at 504 South Rosa Rd., Suite 200, Madison, WI, Axio BioPharma is poised to meet the growing demands of the biopharmaceutical ...
read more
Monday, September 30, 2024
Acumen Pharmaceuticals, Inc. announced that it has extended its collaboration with Lonza to enable the potential future commercial launch of sabirnetug (ACU193).
read more
Monday, September 30, 2024
Aenova, one of the world's leading CDMOs (Contract Development and Manufacturing Organizations) for the pharmaceutical and healthcare industries, is implementing a new gummy line at its site in Cornu, Romania.
read more
Monday, September 30, 2024
The 2024 CPHI Pharma Awards comprise finalists spanning 14 categories and includes awards for future leaders, women of the year, and an “at the heart of pharma” category.
read more
Monday, September 30, 2024
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new state-of-the-art facility in ...
read more
Thursday, September 26, 2024
Phastar has been named as a finalist for the Best Contract Research Organization - Specialist Providers category at the 2024 Scrip Awards. Phastar was recognized for its Clinical Intelligence Portal, a high-quality data analytics, visualization, and ...
read more
Thursday, September 26, 2024
Univo IRB announced the launch of its Canadian research ethics board (REB) review services. This new offering is designed to support clinical trials conducted across North America, ensuring that reviews exceed the industry’s highest standards of ...
read more
Thursday, September 26, 2024
Phesi has launched a self-service Investigator Site Profile solution designed to eliminate the non-active and non-enrolling investigator sites that development programs are typically burdened with. Investigator Site Profile leverages data from Phesi’...
read more
Tuesday, September 24, 2024
Lonza announced the signature of a long-term commercial supply agreement for CASGEVY® (exagamglogene autotemcel).
read more
Tuesday, September 24, 2024
Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has confirmed multi-million-dollar investments supporting global infrastructure of the company. Expanded GMP suite capacity up to 500L scales and the addition of fill finish ...
read more
Tuesday, September 24, 2024
Univo IRB announced the launch of its Canadian research ethics board (REB) review services. This new offering is designed to support clinical trials conducted across North America, ensuring that reviews exceed the industry’s highest standards of ...
read more
Thursday, September 19, 2024
Piramal Pharma Limited embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets.
read more
Thursday, September 19, 2024
Leading global contract development and manufacturing organization (CDMO), PCI Pharma Services (PCI), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.
read more
Tuesday, September 17, 2024
Serán Bioscience announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital remains a key shareholder in the company.
read more